Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation

Location: North Carolina
Posted: Jun 30, 2025
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Contract: Awards
Type of Government: Federal
Category:
  • A - Research and development
Solicitation No: BARDA-IEIDD-063025
Publication URL: To access bid details, please log in.
Follow
Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation
Active
Contract Opportunity
Notice ID
BARDA-IEIDD-063025
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office
ASPR BARDA DIV CONTRACTS MGMT & ACQ
Award Details
  • Contract Award Date: Sep 29, 2023
  • Contract Award Number: 75A50123C00045
  • Task/Delivery Order Number:
  • Modification Number: P00004
  • Contractor Awarded Unique Entity ID:
General Information
  • Contract Opportunity Type: Justification (Original)
  • Original Published Date: Jun 30, 2025 02:50 pm EDT
  • Inactive Policy: 30 days after published date
  • Original Inactive Date: Jul 30, 2025
  • Authority: FAR 6.302-1 - Only one responsible source (except brand name)
  • Initiative:
    • None
Classification
  • Product Service Code: AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
  • NAICS Code:
    • 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • Place of Performance:
    NC 28401
    USA
Description

This procurement is aimed at providing a central laboratory capacity site for analysis of mucosal and serum samples collected from subjects enrolled in multiple USG-sponsored COVID-19 vaccine trials. This action covers efforts to utilize the validated virus neutralization (VN) and binding assays to support these studies. The program goals are:

1. Establish validated VN and binding assays for SARS-CoV-2 emerging variant(s).

2. Test serum samples from human subjects enrolled in clinical trials of COVID-19 vaccine candidates in variant VN and binding antibody assays in compliance with GCLP guidelines.


Attachments/Links
Contact Information
Contracting Office Address
  • 200 C Street, SW
  • Washington , DC 20515
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Jun 30, 2025 02:50 pm EDTJustification (Original)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL
* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.